Ontology highlight
ABSTRACT: Background and objectives
IL-6 (interleukin 6) is a proinflammatory cytokine and an established biomarker in acute brain injury. We sought to determine whether admission IL-6 levels are associated with severity and functional outcome after spontaneous intracerebral hemorrhage (ICH).Methods
We performed an exploratory analysis of the recombinant activated FAST trial (Factor VII for Acute ICH). Patients with admission serum IL-6 levels were included. Regression analyses were used to assess the associations between IL-6 and 90-day modified Rankin Scale. In secondary analyses, we used linear regression to evaluate the association between IL-6 and baseline ICH and perihematomal edema volumes.Results
Of 841 enrolled patients, we included 552 (66%) with available admission
SUBMITTER: Leasure AC
PROVIDER: S-EPMC8085132 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature